This research investigates polyploid giant cancer cells, a highly treatment-resistant population responsible for cancer relapse. By studying their structural biology and dependence on lipid metabolism, the work identifies metabolic vulnerabilities that can be targeted alongside chemotherapy, offering a promising strategy to eliminate resistant cancer cells and improve long-term treatment outcomes.

Late-stage cancers often recur more aggressively after treatment. This research identifies the specific dendritic cell types found inside tumors, distinguishing “good” anti-cancer cells from “bad” tumor-promoting ones. Using this knowledge, a tailored dendritic-cell vaccine is being developed and tested in an ovarian-cancer-like mouse model to prevent relapse.